Audentes Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. TSLA
3. TXN
4. NOW
5. AMD
6. GOOG
7. CSX
8. KNX
9. IBM
10. LVS

Go back to Audentes Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update

Audentes Therapeutics (BOLD) Misses Q1 EPS by 24c

May 7, 2019 4:30 PM EDT

Audentes Therapeutics (NASDAQ: BOLD) reported Q1 EPS of ($1.13), $0.24 worse than the analyst estimate of ($0.89).

For earnings history and earnings-related data on Audentes Therapeutics (BOLD) click here.

... More